How to buy Cytodyn stock (CYDY)

Our top picks for where to buy Cytodyn stock

Buy Cytodyn stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

AS SEEN ON:

Cytodyn is a biotechnology business based in the US. Cytodyn shares (CYDY) are listed on the OTCQB and all prices are listed in US Dollars. Its last market close was $0.12 – the same closing value as a week prior. Cytodyn employs 9 staff and has a market cap (total outstanding shares value) of 0.00.

Cytodyn stock price (OTCQB: CYDY)

Use our graph to track the performance of CYDY stocks over time.

Cytodyn shares at a glance

• Key figures

Information last updated 2024-12-25.

Latest market close	$0.12
52-week range	$0.10 - $0.32
50-day moving average more info button	$0.13
200-day moving average more info button	$0.15
Wall St. target price	$4.00
PE ratio more info button	N/A
Dividend yield more info button	N/A
Earnings per share (TTM) more info button	$-0.02

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Cytodyn stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cytodyn price performance over time

Historical closes compared with the close of $0.12 from 2024-12-26

1 week (2024-12-20)	0.12
1 month (2024-11-27)	0.12
3 months (2024-09-27)	-25.00%
6 months (2024-06-28)	-14.29%

1 year (2023-12-28)	-36.84%
2 years (2022-12-28)	-47.83%
3 years (2021-12-28)	1
5 years (2019-12-27)	0.975

Cytodyn financials

Gross profit TTM	$-20,633,000
Return on assets TTM	-49.45%
Return on equity TTM	0%
Profit margin	0%
Book value	$-0.07
Market Capitalization more info button	$146.4 million

TTM: trailing 12 months

Cytodyn share dividends

We're not expecting Cytodyn to pay a dividend over the next 12 months.

Cytodyn share price volatility

Over the last 12 months, Cytodyn's shares have ranged in value from as little as $0.1 up to $0.32. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Cytodyn's is 0.165. This would suggest that Cytodyn's shares are less volatile than average (for this exchange).

Cytodyn overview

CytoDyn Inc. , a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

Frequently asked questions

What percentage of Cytodyn is owned by insiders or institutions?
Currently 0.783% of Cytodyn shares are held by insiders and 0.033% by institutions. How many people work for Cytodyn?
Latest data suggests 9 work at Cytodyn. When does the fiscal year end for Cytodyn?
Cytodyn's fiscal year ends in May. Where is Cytodyn based?
Cytodyn's address is: 1111 Main Street, Vancouver, WA, United States, 98660 What is Cytodyn's ISIN number?
Cytodyn's international securities identification number is: US23283M1018 What is Cytodyn's CUSIP number?
Cytodyn's Committee on Uniform Securities Identification Procedures number is: 23283M101